VolitionRX Ltd.

VolitionRX Ltd.
Stock Exchange NYSE
EPS
$0.53
Market Cap
$122.79 M
Shares Outstanding
39.48 M
Public Float
22.41 M

Profile

Address
1 Scotts Road
Singapore CE 228208
Singapore
Employees -
Website http://www.volitionrx.com
Updated 07/08/2019
VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Singapore.

Financials

View All
Created with Highcharts 5.0.14VolitionRX Ltd.Net Income. Fiscal year is January-December. All values USD Thousands.3 7103 7108 2138 2139 5309 53011 90511 90514 76914 76918 00818 00820132014201520162017201805k10k15k20k
Created with Highcharts 5.0.14VolitionRX Ltd.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.0014140000006396392013201420152016201720180200400600800

Cameron John Reynolds
President, Chief Executive Officer & Director
Guy Archibald Innes
Lead Independent Non-Executive Director